Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
The Bio Report
Levine Media Group
Farm Food Facts
USFRA
Eye On The Sky
Vermont Public
The Poison Lab
Clinical Toxicology LLC
Answers with Ken Ham
Ken Ham and Mark Looy
Dr. Derek Suite - The SuiteSpot
Derek H. Suite, M.D.
Lake Superior Podcast
National Parks of Lake Superior Foundation
The Green Blueprint
Latitude Media
Medication Talk - Expert Insights on Drug Therapy & Patient Care
TRC Healthcare | Pharmacist's Letter | Prescriber Insights | Pharmacy Technician's Letter
Fox Weather Update
Fox Weather
The Prairie Farm Podcast
Nicolas Lirio & Kent Boucher
Faith and Sustainability
Archdiocese of Atlanta
From the Spectrum: Finding Superpowers with Autism
Ryan Sumner
Inflection Point
C&EN
AI News Podcast | Latest AI News, Analysis & Events | Daily Inference
AI Daily
Ö1 Wissen aktuell
ORF Ö1
SintonIA. La IA en las ondas.
Radiolab UGR
Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc!
Byte & Pieces
Relatos De Horror (Historias De Terror)
Relatos De Horror
منوعات إسلامية
تعليم عقيدة رسول الله
Live Like a Girl with Dr. Mindy Pelz
Dr. Mindy Pelz
Genome Insider
JGI
The 365 Days of Astronomy
365DaysOfAstronomy.org
On The Wing Podcast
On The Wing Podcast by Pheasants Forever and Quail Forever
Talking Pools Podcast
Rudy Stankowitz
Redox Grows
Redox Bio-Nutrients
Los Angeles Weather Daily
Fast Foundations
Phoenix Weather Daily
Fast Foundations
San Diego Weather Daily
Fast Foundations
Ag Geek Speak
A Podcast for Precision Agriculture Geeks
San Francisco Weather Daily
Fast Foundations
Wildlife Investments
Moriah Boggess
The Swine Health Blackbelt Podcast
Wisenetix
Astronomy Daily: Space News Updates
bitesz.com
Kohn's Zone
Alfie Kohn
Risky or Not?
Don Schaffner and Ben Chapman
xHUB.AI
Plácido Doménech Espí
Science
Levine Media Group
Acute ischemic stroke is both ubiquitous and undertreated. Only a small fraction of patients currently receive clot-busting drugs or mechanical thrombectomy because of the small treatment window. That’s because existing ...
Plasma gelsolin is an abundant, endogenous regulator of inflammation that is consumed during severe inflammatory insults. When levels fall too low, patients are at higher risk of organ damage and death, particularly in s...
A chronic shortage of high‑quality targets remains one of the biggest constraints in drug discovery, even as therapeutic tools become more powerful and diverse. Regeneron is tackling that problem with its Regeneron Genet...
Epigenetics, the layer of chemical switches that controls how genes are turned on and off, can act like cancer’s operating system when a single epigenetic enzyme becomes essential for a tumor to survive. K36 Therapeutics...
Most marketed antibodies work as antagonists, simply shutting off a receptor, even though many immune, metabolic, and cancer pathways require more nuanced control. Metaphore Biotechnologies' function‑first platform combi...
Cells continuously sense their environment and in response to stressors, adapt, recover, or die. Soley Therapeutics uses its AI platform to capture thousands of intracellular features and map how cells sense, interpret, ...
Promising drugs can become abandoned or underused because of tolerability issues, poor drug‑like properties, or other fixable limitations, even when there is already compelling human evidence that they work. PureTech Hea...
Most cancer therapies hit one or a few pathways that tumors can escape by mutating, activating alternative survival routes, or pumping drugs out, leading to relapse and poor survival in indications such as liver, ovarian...
Gout may be one of the oldest known forms of arthritis, but it remains widely misunderstood, undertreated, and a source of silent suffering for millions of people who are often blamed for their disease rather than offere...
Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. Mesoblast has spent more than 15 years industrializing mesenchymal stromal cell therapies to...
Most existing therapies for multiple sclerosis do a good job of reducing relapses and inflammatory activity, but they largely fail to stop the slow neurodegeneration that drives long-term disability, especially in progre...
The treatment of inflammatory bowel disease currently relies on immunosuppressive therapies that often lose effectiveness, carry infection risks, and drive high treatment cycling. Abivax is betting that fine-tuning, rath...
Many people with the genetic condition Lynch syndrome live with the near‑certainty that they will one day develop cancer and have few options beyond constant screening and, in some cases, preventive surgery. Nouscom is t...
Alzheimer’s disease drug development has long focused on slowing memory loss, but for many families, the tipping point that makes home care impossible is not cognition—it is psychosis. Hallucinations and delusions in Alz...
RICO, the Racketeer Influenced and Corrupt Organizations Act, was originally designed to prosecute organized crime. Today, it sits at the center of a landmark class action against two of the world’s largest pharmaceutica...
Pancreatic cancer remains one of oncology’s deadliest diagnoses, with standard treatments often offering only transient tumor shrinkage at the cost of grueling side effects and rapid resistance. Immuneering is using tran...
Human leukocyte antigen, or HLA, genes, help the immune system tell the difference between the body’s own tissues and outside threats. In some people, certain versions of HLA genes mistakenly flag normal proteins as dang...
Asia is quickly becoming a powerhouse for biopharma innovation, changing ideas about where breakthrough science and fast, cost-efficient drug development happen. A new McKinsey & Company report shows how countries like C...
Leukemia once threatened Aaron Viny’s life, but now it defines his mission. Diagnosed with acute lymphoblastic leukemia as a college student, he survived chemotherapy, central nervous system relapse, and an allogeneic st...
When Amy Burroughs stepped in as CEO of Terns Pharmaceuticals, she not only had to fill a void created by the death of her predecessor, but also lead a strategic shift from an increasingly crowded area of metabolic disea...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.